Waters Co. (NYSE:WAT) Shares Sold by Texas Permanent School Fund

Share on StockTwits

Texas Permanent School Fund reduced its position in shares of Waters Co. (NYSE:WAT) by 7.2% during the third quarter, HoldingsChannel reports. The firm owned 12,435 shares of the medical instruments supplier’s stock after selling 963 shares during the quarter. Texas Permanent School Fund’s holdings in Waters were worth $2,776,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its position in shares of Waters by 20.7% during the second quarter. JPMorgan Chase & Co. now owns 179,470 shares of the medical instruments supplier’s stock worth $38,312,000 after purchasing an additional 30,822 shares in the last quarter. Cibc World Markets Corp lifted its position in shares of Waters by 278.1% during the second quarter. Cibc World Markets Corp now owns 65,874 shares of the medical instruments supplier’s stock worth $14,179,000 after purchasing an additional 48,450 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. lifted its position in shares of Waters by 40.8% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 2,856 shares of the medical instruments supplier’s stock worth $615,000 after purchasing an additional 828 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in Waters by 46.1% in the second quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 951 shares of the medical instruments supplier’s stock valued at $205,000 after acquiring an additional 300 shares in the last quarter. Finally, First Trust Advisors LP raised its holdings in Waters by 1,148.3% in the second quarter. First Trust Advisors LP now owns 86,505 shares of the medical instruments supplier’s stock valued at $18,619,000 after acquiring an additional 79,575 shares in the last quarter. 95.15% of the stock is currently owned by institutional investors and hedge funds.

WAT opened at $211.98 on Friday. The stock has a market capitalization of $13.76 billion, a PE ratio of 25.57, a P/E/G ratio of 2.54 and a beta of 1.04. The firm’s fifty day moving average price is $218.46 and its 200 day moving average price is $214.21. The company has a debt-to-equity ratio of 11.40, a current ratio of 2.25 and a quick ratio of 1.63. Waters Co. has a 12-month low of $173.41 and a 12-month high of $255.21.

Waters (NYSE:WAT) last released its earnings results on Tuesday, October 29th. The medical instruments supplier reported $2.13 earnings per share for the quarter, meeting the consensus estimate of $2.13. Waters had a net margin of 23.98% and a return on equity of 77.73%. The firm had revenue of $577.28 million during the quarter, compared to analyst estimates of $588.35 million. During the same quarter in the previous year, the firm earned $1.92 earnings per share. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. On average, equities research analysts forecast that Waters Co. will post 8.84 earnings per share for the current fiscal year.

In other Waters news, Director Laurie H. M.D. Glimcher sold 2,200 shares of the business’s stock in a transaction on Friday, November 1st. The shares were sold at an average price of $214.64, for a total transaction of $472,208.00. Following the completion of the sale, the director now owns 3,600 shares in the company, valued at $772,704. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.14% of the stock is owned by insiders.

Several research firms recently issued reports on WAT. Bank of America cut shares of Waters from a “neutral” rating to an “underperform” rating in a report on Tuesday, July 16th. TheStreet cut shares of Waters from a “b” rating to a “c+” rating in a report on Tuesday, October 29th. ValuEngine cut shares of Waters from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Barclays cut shares of Waters from an “equal weight” rating to an “underweight” rating and cut their price target for the company from $210.00 to $195.00 in a report on Wednesday, October 9th. Finally, Robert W. Baird upped their price target on shares of Waters from $208.00 to $217.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. Six analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $209.60.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: What is a CD ladder?

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.